SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-20-013681
Filing Date
2020-06-23
Accepted
2020-06-23 16:49:43
Documents
1
Period of Report
2020-06-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 6736
  Complete submission text file 0001437749-20-013681.txt   8148
Mailing Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007 646-975-2500
PROGENICS PHARMACEUTICALS INC (Issuer) CIK: 0000835887 (see all company filings)

IRS No.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROGENICS PHARMACEUTICALS, INC. 1 WORLD TRADE CENTER, 47TH FL, SUITE J NEW YORK NY 10007
Business Address
Das Asha (Reporting) CIK: 0001701647 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23143 | Film No.: 20982741